Home Reimbursed medicines Imatinib
Imatinib — maximum prices and reimbursement
The CANAMED catalogue contains 68 medicines with the active substance Imatinib, from 6 manufacturers. Below you can see each entry with the brand name, the manufacturer, the maximum retail price, the reimbursement percentage and the prescription status — plus live pharmacy prices, where we track them.
In short: for the active substance Imatinib there are 68 authorised medicines in the CANAMED catalogue, with maximum retail prices between 336.51 and 6801.15 RON, from 6 manufacturers. For 10 of them the catalogue also records the reimbursement percentage. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.
Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.
CANAMED catalogue
All medicines with Imatinib
Maximum retail price = the legal selling cap. Sorted by price, lowest first.
| Brand name | Manufacturer | Maximum price | Reimbursement | Prescription |
|---|---|---|---|---|
| IMATINIB ACCORD 100 mg | ACCORD HEALTHCARE POLSKA SP.Z O.O. - POLONIA | 336.51 RON | 100% · C2 (national programmes) CNAS pays ~336.51 RON; you ~0.00 RON* |
PR |
| IMATINIB ACCORD 100 mg | ACCORD HEALTHCARE POLSKA SP.Z O.O. - POLONIA | 336.51 RON | 100% · C2 (national programmes) CNAS pays ~336.51 RON; you ~0.00 RON* |
PR |
| IMATINIB TERAPIA 100 mg | TERAPIA SA - ROMANIA | 403.58 RON | 100% · C2 (national programmes) CNAS pays ~403.58 RON; you ~0.00 RON* |
PR |
| IMATINIB TERAPIA 400 mg | TERAPIA SA - ROMANIA | 541.55 RON | 100% · C2 (national programmes) CNAS pays ~541.55 RON; you ~0.00 RON* |
PR |
| IMATINIB STADA 100 mg | STADA ARZNEIMITTEL AG - GERMANIA | 628.59 RON | 100% · C2 (national programmes) CNAS pays ~403.81 RON; you ~224.78 RON* |
PR |
| IMATINIB ACCORD 400 mg | ACCORD HEALTHCARE POLSKA SP.Z O.O. - POLONIA | 780.06 RON | 100% · C2 (national programmes) CNAS pays ~649.86 RON; you ~130.20 RON* |
PR |
| IMAKREBIN 100 mg | REMEDICA LTD. - CIPRU | 807.62 RON | 100% · C2 (national programmes) CNAS pays ~807.62 RON; you ~0.00 RON* |
PR |
| IMATINIB STADA 400 mg | STADA ARZNEIMITTEL AG - GERMANIA | 855.89 RON | 100% · C2 (national programmes) CNAS pays ~649.86 RON; you ~206.03 RON* |
PR |
| IMAKREBIN 400 mg | REMEDICA LTD. - CIPRU | 936.07 RON | 100% · C2 (national programmes) CNAS pays ~649.86 RON; you ~286.21 RON* |
PR |
| IMATINIB GRINDEKS 100 mg | AS GRINDEKS - LETONIA | 6801.15 RON | 100% · C2 (national programmes) CNAS pays ~807.62 RON; you ~5993.53 RON* |
PR |
| IMAKREBIN 100 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PR |
| IMAKREBIN 100 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PR |
| IMAKREBIN 100 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PR |
| IMAKREBIN 100 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PR |
| IMAKREBIN 100 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PR |
| IMAKREBIN 100 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PR |
| IMAKREBIN 400 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PR |
| IMAKREBIN 400 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PR |
| IMAKREBIN 400 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PR |
| IMAKREBIN 400 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PR |
| IMAKREBIN 400 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PR |
| IMAKREBIN 400 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PR |
| IMATINIB GRINDEKS 100 mg | AS GRINDEKS - LETONIA | — | not reimbursed | PR |
| IMATINIB GRINDEKS 100 mg | AS GRINDEKS - LETONIA | — | not reimbursed | PR |
| IMATINIB STADA 100 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| IMATINIB STADA 100 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| IMATINIB STADA 100 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| IMATINIB STADA 100 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| IMATINIB STADA 100 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| IMATINIB STADA 400 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| IMATINIB STADA 400 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| IMATINIB STADA 400 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 100 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 100 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 100 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 100 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 100 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 100 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 100 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 100 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 400 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 400 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 400 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 400 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 400 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 400 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 400 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| IMATINIB TERAPIA 400 mg | TERAPIA SA - ROMANIA | — | not reimbursed | PR |
| MEAXIN 100 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 100 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 100 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 100 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 100 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 100 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 100 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 100 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 100 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 100 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 100 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 100 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 400 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 400 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 400 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 400 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 400 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 400 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 400 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| MEAXIN 400 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
Reimbursement and amounts come from the CNAS nomenclature (SIUI) valid in the current month, for each pack. *What you pay is indicative: the maximum price minus what CNAS pays on the main sublist, for an insured adult. The pharmacy may sell below the maximum price; low-income pensioners, children, pupils and pregnant women may pay less. C1 applies only to the diseases on the list, and C2 within the national programmes.
Prescription status key:
- PR — With a medical prescription (PR)
Live pharmacy prices
Products with Imatinib in our comparator
Shelf prices collected from the large chains — see on each product page where it is cheapest.
Good to know
How to read the maximum price
The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.
CANAMED catalogue
Other active substances in the catalogue
- Ibuprofen
- Irbesartan
- Ivabradin
- Ioversol
- Imunoglobulina normala pt adm intravasculara
- Imunoglobulina umana normala
- Ivacaftor
- Insulin glulizina
- Irinotecan
- Indapamid
See also the full list of reimbursed medicines, with an alphabetical index of all active substances.
Frequently asked questions
FAQ · Imatinib
-
Is Imatinib reimbursed?
Yes. For 10 of the catalogue entries with Imatinib we have the reimbursement percentage on record. The percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price of the therapeutic group, not to the shelf price. Ask the doctor or pharmacist for the exact placement. -
What is the CANAMED maximum price for Imatinib?
The maximum retail prices (the CANAMED legal cap) for medicines with Imatinib are between 336.51 and 6801.15 RON. No pharmacy may sell above the maximum price, but it may sell below it — compare real prices with the HartaFarmacii comparator. -
What percentage of Imatinib is reimbursed?
The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription. -
How many medicines with Imatinib are in the CANAMED catalogue?
The CANAMED catalogue holds 68 authorised medicines with the active substance Imatinib — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.
Before you go